Christopher Philip Bridge, D.Phil.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology Information Systems | 1 | 2022 | 523 | 0.610 |
Why?
|
Fetal Heart | 1 | 2016 | 276 | 0.510 |
Why?
|
Radiology | 3 | 2023 | 2099 | 0.470 |
Why?
|
Sarcopenia | 3 | 2023 | 368 | 0.440 |
Why?
|
Artificial Intelligence | 5 | 2024 | 2210 | 0.310 |
Why?
|
Ultrasonography | 2 | 2023 | 5986 | 0.250 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3320 | 0.230 |
Why?
|
Pneumothorax | 1 | 2023 | 378 | 0.180 |
Why?
|
Body Composition | 4 | 2023 | 2401 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20121 | 0.170 |
Why?
|
Glioblastoma | 2 | 2024 | 3480 | 0.160 |
Why?
|
Brain Neoplasms | 3 | 2024 | 8856 | 0.160 |
Why?
|
Ecosystem | 1 | 2022 | 473 | 0.160 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 537 | 0.150 |
Why?
|
Spinal Neoplasms | 1 | 2023 | 760 | 0.140 |
Why?
|
Trauma Centers | 1 | 2021 | 891 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5230 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2021 | 696 | 0.120 |
Why?
|
Algorithms | 5 | 2024 | 13869 | 0.120 |
Why?
|
Automation | 1 | 2016 | 584 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13112 | 0.120 |
Why?
|
Pneumonectomy | 1 | 2020 | 1098 | 0.110 |
Why?
|
Medicine | 1 | 2021 | 945 | 0.110 |
Why?
|
Outpatients | 1 | 2020 | 1488 | 0.110 |
Why?
|
Osteoporosis | 1 | 2021 | 1577 | 0.100 |
Why?
|
Muscle, Skeletal | 3 | 2023 | 4925 | 0.100 |
Why?
|
Weight Loss | 1 | 2021 | 2625 | 0.090 |
Why?
|
Glioma | 1 | 2024 | 3401 | 0.080 |
Why?
|
Electrocardiography | 1 | 2021 | 6441 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2023 | 8939 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19894 | 0.070 |
Why?
|
Humans | 21 | 2024 | 743811 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5319 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 21675 | 0.060 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 288 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 205 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14714 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Anisotropy | 1 | 2024 | 1263 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9975 | 0.050 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 476 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3503 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 359 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 847 | 0.040 |
Why?
|
Tumor Burden | 1 | 2023 | 1917 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 592 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2023 | 1001 | 0.040 |
Why?
|
Benchmarking | 1 | 2024 | 1042 | 0.040 |
Why?
|
Frail Elderly | 1 | 2021 | 693 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2023 | 77410 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2298 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1117 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 1624 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1988 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 1177 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2021 | 976 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2899 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2305 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4974 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4670 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 2267 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2039 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 35409 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3706 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 7010 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25032 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3639 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2023 | 15281 | 0.020 |
Why?
|
Aged | 4 | 2021 | 163178 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6311 | 0.020 |
Why?
|
Male | 5 | 2023 | 349776 | 0.020 |
Why?
|
Software | 1 | 2021 | 4440 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3953 | 0.020 |
Why?
|
Brain | 2 | 2024 | 26345 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9858 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.020 |
Why?
|
Prognosis | 1 | 2023 | 29052 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 213241 | 0.010 |
Why?
|
Female | 4 | 2021 | 380020 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12744 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40545 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29777 | 0.010 |
Why?
|
United States | 1 | 2023 | 69859 | 0.010 |
Why?
|
Adult | 1 | 2023 | 213889 | 0.010 |
Why?
|